Quick Answer
BALCHEM CORP reported Total Revenue of $1.04 billion for fiscal year 2025.
BALCHEM CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.04B +8.8% |
$953.68M +3.4% |
$922.44M -2.1% |
$942.36M +17.9% |
$799.02M +13.6% |
$703.64M +9.3% |
| Revenue (ASC 606) | $1.04B +8.8% |
$953.68M +3.4% |
$922.44M -2.1% |
$942.36M +17.9% |
$799.02M +13.6% |
$703.64M +9.3% |
| Net Income | $154.84M +20.5% |
$128.47M +18.4% |
$108.54M +3.0% |
$105.37M +9.6% |
$96.10M +13.6% |
$84.62M +6.2% |
| Diluted EPS | $4.75 +20.9% |
$3.93 +17.3% |
$3.35 +3.1% |
$3.25 +10.5% |
$2.94 +13.1% |
$2.60 +6.1% |
| Total Assets | $1.69B +7.0% |
$1.58B -1.4% |
$1.60B -1.7% |
$1.62B +35.5% |
$1.20B +2.9% |
$1.17B +0.9% |
| Cash and Equivalents | $74.57M +50.6% |
$49.52M -23.2% |
$64.45M -3.2% |
$66.56M -35.5% |
$103.24M +22.1% |
$84.57M +28.8% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $1.26B +9.3% |
$1.15B +9.1% |
$1.05B +12.3% |
$938.28M +7.0% |
$877.01M +5.9% |
$828.23M +11.4% |
| R&D Expense | $18.51M +10.2% |
$16.79M +11.6% |
$15.05M +23.4% |
$12.19M -9.9% |
$13.52M +30.9% |
$10.33M -9.2% |
| Operating Income | $209.33M +14.4% |
$182.91M +14.9% |
$159.19M +9.6% |
$145.19M +13.9% |
$127.50M +14.7% |
$111.15M +8.4% |
| Gross Profit | $370.63M +10.2% |
$336.21M +11.3% |
$302.06M +7.7% |
$280.45M +15.3% |
$243.17M +8.6% |
$223.90M +5.9% |
| Shares Outstanding | 32.06M -1.4% |
32.53M +0.8% |
32.25M +0.3% |
32.15M -0.4% |
32.29M -0.3% |
32.37M +0.5% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $267.56M | +11.5% | +4.7% |
| Revenue (ASC 606) | September 30, 2025 | $267.56M | +11.5% | +4.7% |
| Net Income | September 30, 2025 | $40.29M | +19.1% | +5.3% |
| Diluted EPS | September 30, 2025 | $1.24 | +20.4% | +6.0% |
| Total Assets | September 30, 2025 | $1.66B | +4.0% | -1.0% |
| Cash and Equivalents | September 30, 2025 | $65.09M | -11.7% | -0.5% |
| Long-Term Debt | September 30, 2018 | $0.00 | -100.0% | — |
| Stockholders Equity | September 30, 2025 | $1.30B | +10.2% | +2.4% |
| R&D Expense | September 30, 2025 | $4.50M | +3.9% | +4.6% |
| Operating Income | September 30, 2025 | $54.58M | +13.7% | +6.1% |
| Gross Profit | September 30, 2025 | $95.45M | +11.8% | +2.5% |
| Shares Outstanding | September 30, 2025 | 32.38M | -0.4% | -0.2% |
- BALCHEM CORP reported Total Revenue of $1.04 billion for fiscal year 2025.
- BALCHEM CORP showed an increase of +8.8% in Total Revenue compared to the prior fiscal year.
- BALCHEM CORP reported Revenue (ASC 606) of $1.04 billion for fiscal year 2025.
- BALCHEM CORP showed an increase of +8.8% in Revenue (ASC 606) compared to the prior fiscal year.
- BALCHEM CORP reported Net Income of $154.84 million for fiscal year 2025.
- BALCHEM CORP showed an increase of +20.5% in Net Income compared to the prior fiscal year.
- BALCHEM CORP reported Diluted EPS of $4.75 per share for fiscal year 2025.
- BALCHEM CORP showed an increase of +20.9% in Diluted EPS compared to the prior fiscal year.
- BALCHEM CORP reported Total Assets of $1.69 billion for fiscal year 2025.
- BALCHEM CORP showed an increase of +7.0% in Total Assets compared to the prior fiscal year.
- BALCHEM CORP reported Cash and Equivalents of $74.57 million for fiscal year 2025.
- BALCHEM CORP showed an increase of +50.6% in Cash and Equivalents compared to the prior fiscal year.
- BALCHEM CORP reported Long-Term Debt of $156.00 million for fiscal year 2018.
- BALCHEM CORP reported Stockholders Equity of $1.26 billion for fiscal year 2025.
- BALCHEM CORP showed an increase of +9.3% in Stockholders Equity compared to the prior fiscal year.
- BALCHEM CORP reported R&D Expense of $18.51 million for fiscal year 2025.
- BALCHEM CORP showed an increase of +10.2% in R&D Expense compared to the prior fiscal year.
- BALCHEM CORP reported Operating Income of $209.33 million for fiscal year 2025.
- BALCHEM CORP showed an increase of +14.4% in Operating Income compared to the prior fiscal year.
- BALCHEM CORP reported Gross Profit of $370.63 million for fiscal year 2025.
- BALCHEM CORP showed an increase of +10.2% in Gross Profit compared to the prior fiscal year.
- BALCHEM CORP reported Shares Outstanding of 32.06 million shares for fiscal year 2025.
- BALCHEM CORP showed a decrease of -1.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: